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Summary
Despite the well-established role of liver X receptors (LXRs) in regulating cholesterol homeostasis, their contribution to
lipid homeostasis remains unclear. Here we show that LXR null mice are defective in hepatic lipid metabolism and are
resistant to obesity when challenged with a diet containing both high fat and cholesterol. This phenotype is dependent
on the presence of dietary cholesterol and is accompanied by the aberrant production of thyroid hormone in liver. Interest-
ingly, the inability of LXR−/− mice to induce SREBP-1c-dependent lipogenesis does not explain the LXR−/− phenotype,
since SREBP-1c null mice are not obesity resistant. Instead, the LXR−/− response is due to abnormal energy dissipation
resulting from uncoupled oxidative phosphorylation and ectopic expression of uncoupling proteins in muscle and white
adipose. These studies suggest that, by selectively sensing the cholesterol component of a lipid-rich diet, LXRs govern
the balance between storage and oxidation of dietary fat.Introduction
The ability to store dietary fat and then utilize it as an energy
source during times of privation is central to the survival of
most animal species. An imbalance in this process can lead to
serious health risks. As an example, obesity and its associated
metabolic syndrome, characterized by onset of type II diabe-
tes, hypertension, and heart disease, have reached epidemic
levels in Western countries and are becoming increasingly
prevalent worldwide (Grundy, 2004). Understanding the regula-
tory pathways that govern energy intake and storage (i.e., fat
accumulation) versus energy expenditure (i.e., fat oxidation) is
key to understanding diseases such as obesity. Recent efforts
have begun to decipher the genetic as well as the environment-
induced mechanisms underlying such an imbalance. Included
in these studies has been the characterization of several trans-
genic mouse models that are resistant to diet-induced obesity.
Most target genes identified in these studies fall into functional
categories that either disturb normal adipocyte differentiation
and lipid storage (Pparg, Hmgi-c), affect lipid synthesis (Dgat,
Complement c3, Scd-1) or hydrolysis (Perilipin), increase fatty
acid oxidation (Acc2, Pgc1b, Ppard) and energy uncoupling
(Ucp-1, Ucp-3, Cidea), or modulate intracellular signaling in dif-
ferent tissues (Pkariib, Ptp1b, Ikkb, S6k1) (Chen and Farese,
2001; Ntambi et al., 2002; Kamei et al., 2003; Wang et al.,
2003; Kopecky et al., 1995; Li et al., 2000; Clapham et al.,
2000; Zhou et al., 2003; Yuan et al., 2001; Um et al., 2004).
The diversity of obesity-resistance genes leading to a com-CELL METABOLISM : APRIL 2005 · VOL. 1 · COPYRIGHT © 2005 ELSEVmon phenotype characterized by increased energy expendi-
ture, enhanced glucose tolerance, and insulin sensitivity sug-
gests the existence of a common set of factors that govern fat
utilization (Chen and Farese, 2001). Candidate factors are likely
to be upstream regulators capable of coordinating responses
between different tissues and modifying the body’s response
to different lipid constituents of the diet. In this respect, mem-
bers of the retinoid X receptor (RXR) heterodimer class of
nuclear receptors are ideal candidates, since they bind to diet-
derived lipophilic molecules and thereby modulate tissue-spe-
cific expression of downstream target genes involved in lipid
homeostasis (Chawla et al., 2001). For example, the peroxi-
some proliferator-activated receptors (PPARα, PPARγ, and
PPARδ) are activated by fatty acid derivatives, which in turn
regulate gene networks that promote lipid synthesis and stor-
age in adipocytes (PPARγ), or activate oxidation pathways in
liver (PPARα) and muscle and brown adipocytes (PPARδ) (Ev-
ans et al., 2004). Likewise, the PPARγ coactivators PGC1α and
PGC1β play essential roles in regulating energy metabolism in
response to external stimuli by inducing fatty acid oxidation
and hepatic gluconeogenesis (Puigserver and Spiegelman,
2003; Lin et al., 2002; Lin et al., 2003). The liver X receptors
(LXRα and LXRβ) represent a second subset of lipid-sensing
receptors that are well-known for their ability to sense oxyste-
rols and regulate genes that decrease total body cholesterol
levels (reviewed by Tontonoz and Mangelsdorf [2003]). LXRs
are also potent stimulators of fatty acid and triglyceride synthe-
sis. This effect is mediated in large part by LXR-dependentIER INC. DOI 10.1016/j.cmet.2005.03.001 231
A R T I C L Ehepatic expression of sterol regulatory element binding pro-
tein-1c (SREBP-1c) and its downstream targets, stearoyl-CoA
desaturase-1 (SCD-1), acyl-CoA carboxylase (ACC), and fatty
acid synthase (FAS) (Repa et al., 2000a; Yoshikawa et al.,
2001). Pertinent to the present study, mice lacking SCD-1 and
ACC-2 are resistant to obesity through increased lipid oxida-
tion and energy expenditure (Ntambi et al., 2002; Abu-Elheiga
et al., 2003). Taken together with the finding that cholesterol
is often a component of a high-fat diet and shares common
metabolic pathways with lipids, we explored the possibility that
LXR regulation of lipid metabolism is interdependent on its abil-
ity to maintain cholesterol homeostasis.
In this study, we show that LXR null mice are defective in
hepatic lipid metabolism and resistant to obesity when chal-
lenged with a Western-style diet containing both high fat and
cholesterol. This phenotype is dependent on the presence of
dietary cholesterol and is accompanied by the abnormal oxida-
tion of fat in peripheral tissues. Importantly, this phenotype is
independent of SREBP-1c, which is known to govern diet-
induced hepatic lipogenesis and is a well-known target gene of
the LXRs. Instead, we show that at least part of the mechanism
driving the LXR−/− response may be due to abnormal, choles-
terol-dependent production of thyroid hormone in liver and to
the net increase in the energy utilization in muscle and white
adipose. Altogether, these studies suggest a dual role for LXRs,
which, by limiting accumulation of diet-derived cholesterol,
permit the normal uptake and storage of dietary fat, a crucial
element of a mammal’s ability to efficiently utilize an important
source of dietary fuel.
Results
Resistance to diet-induced obesity in LXR−/− mice
requires dietary cholesterol
To study the role of LXRs in dietary fat metabolism, wild-type
and LXRα/LXRβ double-knockout (LXR−/−) mice were main-
tained for 7 weeks on one of three diets: a standard rodent
chow diet (4% fat; %0.04% cholesterol), a Western diet con-
taining high fat and high cholesterol (21% milk fat, 0.2% cho-
lesterol), or a high-fat-only diet, which has the same compo-
nents as the Western diet but with no added cholesterol (21%
milk fat; %0.05% cholesterol). As expected, wild-type mice
gained weight significantly (up to 30% increase) when fed
either of the high-fat diets compared to the standard chow diet
(Figures 1A and 1B). In contrast, LXR−/− mice were 15%–20%
leaner than their wild-type littermates at the beginning of the
experiment and were resistant to weight gain when fed the
Western diet (Figure 1A). Surprisingly, when the LXR−/− mice
were maintained on the same diet without added cholesterol
(i.e., the high-fat-only diet), they gained weight at the same rate
and to the same extent as wild-type controls (Figure 1B). These
same mice were also subjected to nuclear magnetic resonance
(NMR) spectrometry to measure total body lipids on all three
diets. NMR analysis showed that the observed changes in
body weights in wild-type mice on a Western or high-fat-only
diet and LXR−/− mice fed the high-fat-only diet were due to
a 3-fold increase in body fat after 7 weeks of feeding (data
not shown).
To examine whether obesity resistance in LXR−/− mice was
due to alterations in feeding behavior, caloric intake and fat
absorption were also measured. Despite their inability to gain232weight on Western diet, LXR−/− mice exhibited a caloric intake
per lean body mass that was comparable to that of wild-type
mice fed the same diet (Figure 1C). When integrated into a
formula that takes into consideration food intake, stool output,
and lipid content, no significant changes in fat absorption were
observed in LXR−/− mice compared to wild-type mice on West-
ern diet (Figure 1D). These results revealed that LXR−/− mice
are unable to store dietary fat in spite of normal food intake
and absorption, and, thus, they are resistant to diet-induced
obesity. Furthermore, this resistance required the inclusion of
cholesterol as a component of the lipid-enriched diet.
Protection from hyperlipidemia and insulin resistance
in LXR−/− mice
To further characterize the obesity resistant phenotype in LXR−/−
mice fed a high-fat/high-cholesterol diet, lipid and carbohy-
drate metabolism were analyzed. As expected from previous
work (Peet et al., 1998), LXR−/− mice accumulated significantly
more hepatic cholesterol compared to wild-type littermates
when maintained on the Western diet (Figure 2A). Total plasma
cholesterol was elevated in both wild-type and LXR−/− mice fed
the Western diet, albeit to a lesser extent in LXR−/− mice (Figure
2B). Lipoprotein analysis revealed that, in wild-type animals,
this increase in plasma cholesterol was all in the HDL fraction,
while, in the LXR−/− mice, only the LDL/IDL fraction increased
(Figure 2C). These findings are consistent with the notion that
LXRs are required for governing reverse cholesterol transport
by elevating HDL cholesterol and increasing hepatic choles-
terol catabolism and excretion (Repa and Mangelsdorf, 2002).
In contrast to cholesterol, triglyceride metabolism was al-
tered diametrically in LXR−/− animals. The Western diet in-
creased hepatic triglycerides 8-fold in wild-type mice as ex-
pected, but no significant increase was observed in LXR−/−
mice (Figure 2D). LXR−/− mice also maintained markedly lower
plasma triglycerides and free fatty acids independent of diet,
while both of these lipid pools increased significantly in wild-
type mice on the Western diet (Figures 2E and 2G). Lipoprotein
analysis revealed that LXR−/− animals had substantially lower
triglycerides in their VLDL fraction on a chow diet, and this
level was reduced further upon feeding the Western diet (Figure
2F). This result is consistent with the finding that hepatic fatty
acid synthesis rates were markedly suppressed (60%–80%) in
LXR−/− mice fed either chow or Western diet (Figure 2H) and
supports the notion that dietary lipids were cleared from
plasma by uptake and utilization in the periphery (see below).
As an indicator of body fat and insulin resistance, and consis-
tent with their obesity and hyperlipidemia, leptin and insulin
levels in wild-type mice increased substantially (6-fold) on the
Western diet compared to standard chow (Figures 2I and 2J).
In comparison, basal levels of both plasma leptin and insulin
were lower in LXR−/− mice and did not increase significantly
when challenged with the Western diet (Figures 2I and 2J).
Moreover, when injected with D-glucose, LXR−/− mice, which
had lower fasting plasma glucose levels than wild-type mice,
maintained significantly lower blood glucose levels at all as-
sayed time points (Figure 2K). Consistent with their similar
gains in weight, wild-type and LXR−/− mice fed the high-fat-
only diet showed high levels of plasma insulin and leptin levels
that were comparable to wild-type mice fed a Western diet
(data not shown). Together, these results provide further evi-
dence that the presence of dietary cholesterol plays an impor-CELL METABOLISM : APRIL 2005
LXR regulation of dietary fat and cholesterolFigure 1. Cholesterol-dependent resistance to diet-
induced obesity in LXR−/− mice
A and B) Growth curves of wild-type and LXR−/−
mice (n = 5) fed chow versus Western diet (A) or
chow versus high-fat-only diet (B).
C) Caloric intake of wild-type and LXR−/− mice (n =
6) after 7 weeks of feeding. Caloric intake (kcal/g
lean body mass [LBM]/day) = food intake (g diet/g
LBM/day) × caloric value of diet (kcal/g). Note that
chow diet has 3.23 kcal/g; lipid-rich diets have 4.53
kcal/g.
D) Fat absorption of wild-type and LXR−/− mice (n =
5) measured on week 5 of feeding. Fat absorption =
([food intake × food lipid content] − [stool output ×
stool lipid content])/(food intake × food lipid con-
tent) × 100. *p < 0.05, **p < 0.01.tant role in protecting LXR−/− mice from the effects of diet-
induced hyperlipidemia.
Altered expression of genes involved in hepatic lipid
metabolism in LXR−/− mice
To address the mechanism by which LXR−/− mice metabolize
dietary fat, we performed a real-time, quantitative PCR (QPCR)
analysis of genes involved in the regulation of lipid metabolism
in four tissues known to play a major role in this regulation,
namely liver, muscle, and white and brown adipose tissues
(Figures 3 and 5; see Figure S1 in the Supplemental Data avail-
able with this article online). Expression data were collected
from both wild-type and LXR−/− mice fed either standard chow
or high-fat diets for 7 weeks. In liver, marked changes were
seen in the expression of genes involved in cholesterol, lipid,
and carbohydrate metabolism, supporting previous work from
our laboratory and others showing liver to be a major target
organ of LXR (reviewed in Tontonoz and Mangelsdorf [2003]).
As expected, LXR target genes involved in elimination of di-
etary cholesterol by catabolism (Cyp7a1) and biliary excretion
(Abcg5, Abcg8) were not regulated in LXR−/− mice as in wild-
type mice; similar data were observed for genes governing glu-
cose metabolism (Figure S1A). Expression of genes involved in
β oxidation of fatty acids (e.g., carnitine palmitoyltransferase-
1a, Cpt-1a; acyl-CoA oxidase, Aco; very long chain acyl-CoA
dehydrogenase; Vlcad) were not affected by the loss of LXRs,
and coincidently, expression of genes in the PPARα metabolicCELL METABOLISM : APRIL 2005cascade remained relatively unchanged or were decreased in
LXR−/− mice (Figure S1A). However, in concordance with their
altered hepatic lipid metabolism, expression of virtually every
gene involved in fatty acid and triglyceride synthesis was de-
creased below basal levels in LXR−/− animals (e.g., Fas, Acc1,
Scd-1, Spot14, malic enzyme [Me]) (Figure 3A; Figure S1A). In
particular, expression of Srebp-1c, which encodes the tran-
scriptional regulator of the genes in this pathway, was reduced
to well below basal levels in LXR−/− animals under all dietary
conditions, supporting the conclusion that LXRs are crucial for
both basal and diet-inducible expression of hepatic SREBP-1c.
To test whether the resistance to obesity in LXR−/− mice was
due to the loss of the SREBP-1c lipogenic pathway, SREBP-
1c−/− mice were subjected to the same dietary analysis de-
scribed above for LXR−/− and wild-type mice. Despite their
smaller body weight at the beginning of the experiment,
SREBP-1c−/− mice were not protected against diet-induced
obesity and, like their wild-type littermates, gained significantly
more weight (25%) when fed a Western versus standard chow
diet (Figure 4A). NMR measurements of total body lipids re-
vealed a 150%–200% increase in body fat over body weight
(BF/BW) ratio in SREBP-1c−/− mice similar to the one observed
in wild-type mice (Figure 4B). Consistent with their increased
weight gain and in contrast to LXR−/− mice, SREBP-1c−/− mice
had increased triglyceride levels in liver, but not in plasma, and
increased plasma free fatty acids, insulin, and leptin levels in
response to Western diet feeding (Figures 4C–4G). In addition,233
A R T I C L EFigure 2. Liver and plasma lipid metabolism in wild-type and LXR−/− mice in response to diet
A–J) Measurements of hepatic cholesterol (n = 5) (A), total plasma cholesterol (n = 3) (B), cholesterol in fractionated lipoproteins (n = 3) (C), hepatic triglycerides (n =
5) (D), plasma triglycerides (n = 3) (E), triglycerides in fractionated lipoproteins (n = 5) (F), plasma-free fatty acids (n = 3) (G), hepatic fatty acid synthesis rates (n = 4)
(H), plasma leptin (n = 3) (I), and plasma insulin (n = 3) (J) were taken from wild-type (wt) and LXR−/− mice after feeding different diets (C, chow; W, Western). In (C) and
(F), open triangles refer to chow-fed and closed circles refer to Western-fed mice. Hepatic fatty acid synthesis rates were determined at 17 days, liver chemistries and
lipoprotein triglycerides at 7 weeks, and other plasma chemistries at 3 weeks after feeding.
K) Glucose tolerance test of wild-type and LXR−/− mice fed a chow diet. After an overnight fast, mice (n = 3 to 5) were injected with 1 g D-glucose/kg body weight,
and tail vein glucose was assayed at 15, 30, 45, 60, and 120 min after injection.
VLDL, LDL, IDL, and HDL refer to very low, low, intermediate, and high-density lipoproteins, respectively. *p < 0.05, **p < 0.01.234 CELL METABOLISM : APRIL 2005
LXR regulation of dietary fat and cholesterolFigure 3. Liver gene expression in wild-type and LXR−/− mice in response to diet
A and B) mRNA expression of lipogenic genes (A) and nonlipogenic thyroid hormone target genes (B) in liver of wild-type (wt) and LXR−/− mice (n = 5) fed chow,
Western, or high-fat-only diets for 7 weeks.
C and D) mRNA expression (C) and enzymatic activity (D) of type II (DIO2), type I (DIO1), and type III (DIO3) iodothyronine deiodinases in liver of wild-type (wt) and
LXR−/− mice fed standard chow, Western, or high-fat-only diets for 7 weeks (n = 5). Cycle time of the highest expressing group for each gene is indicated inside its
corresponding bar. mRNA levels were determined by QPCR using the comparative CT method.
In (A), * indicates statistical difference between mice of the same genotype fed different diets, and # indicates statistical difference between this value and that of all
mouse groups of the other genotype (p < 0.05). In (B), (C), and (D), *p < 0.05 and **p < 0.01 indicate statistical difference between this and all other values.CELL METABOLISM : APRIL 2005 235
A R T I C L EFigure 4. Susceptibility to diet-induced obesity in
SREBP-1c−/− mice
A and B) Growth curves (A) and percent increase in
body fat over body weight (BF/BW) ratio (B) for wild-
type (wt) and SREBP-1c−/− mice (n = 6) fed chow
versus Western diet for 7 weeks.
C–I) Measurements of liver triglycerides (C), plasma
triglycerides (D), plasma-free fatty acids (E), plasma
insulin (F), plasma leptin (G), liver cholesterol (H),
and plasma cholesterol (I) were determined from
wild-type (wt), LXR−/−, and SREBP-1c−/− mice fed
for 7 weeks (C, chow; W, Western, n = 5). In (C) and
(H), * indicates p < 0.01. In (D−G) and (I), * indicates
statistical significance between animals of the same
genotype fed different diets; # indicates significance
between this value and that of mice from the other
two genotypes (p < 0.05).236 CELL METABOLISM : APRIL 2005
LXR regulation of dietary fat and cholesterolliver and plasma cholesterol levels were similar in wild-type and
SREBP-1c−/− mice on both diets (Figures 4H and 4I). Therefore,
the obesity resistance phenotype of LXR−/− mice cannot be
explained by the loss of SREBP-1c expression in these an-
imals.
Cholesterol-dependent thyroid hormone production
in LXR−/− mice
In contrast to the fatty acid synthesis genes described above,
expression of a limited set of other genes involved in fatty acid
utilization (e.g., uncoupling protein-2, Ucp-2; β2-adrenergic re-
ceptor, b2AR; fatty acid transport protein-1, Fatp-1; lipoprotein
lipase, Lpl) were significantly increased in liver of LXR−/− mice
but only when both cholesterol and fat were included as part
of the diet (Figure 3B). Many of these genes are known targets
of thyroid hormone, and, in parallel with their regulation, there
was an unprecedented induction of hepatic type II iodothyro-
nine deiodinase (Dio2) expression in LXR−/− mice when fed the
Western diet but not chow or high-fat-only diets (Figure 3C,
top). Dio2 encodes one of two enzymes that produce active
thyroid hormone (T3) from its inactive precursor (T4). DIO2 is
the main source of tissue-specific T3 production and is known
to deliver the newly synthesized hormone directly to the T3
receptor in the nucleus (reviewed by Bianco et al. [2002]). Al-
though not normally expressed in liver, hepatic DIO2 mRNA
levels found in LXR−/− mice on the Western diet were compara-
ble to those in wild-type skeletal muscle (Figure 5A) but less
than in wild-type brown fat on the same diet (Figure S1B). In
accordance with mRNA levels, hepatic DIO2 enzyme activity
was also markedly induced in LXR−/− mice fed only the West-
ern diet (Figure 3D, top). Type I deiodinase (DIO1), which is
known to be autoregulated by T3, was also increased slightly
(Figures 3C and 3D, middle). No differences were detected in
the deactivating, type III deiodinase (DIO3) (Figures 3C and 3D,
bottom). Interestingly, despite the level of DIO2 in liver, no
changes in plasma T3, T4, or thyroid-stimulating hormone
levels were detected (data not shown), consistent with the well-
documented role of DIO2 in elevating tissue T3 levels and af-
fecting T3 target genes without influencing plasma T3 levels
(de Jesus et al., 2001; Pachucki et al., 2001; Schneider et al.,
2001). Importantly, T3 target genes involved in lipogenesis
(Fas, Acc, Scd-1, Me, ATP-citrate lyase [Acl], glycerol-3-phos-
phate acyltransferase [Gpat], Spot14) were not induced but
downregulated in LXR−/− mice (Figure 3A; Figure S1A). This ob-
servation was consistent with the low level of SREBP-1c in
these mice, which is required for thyroid hormone regulation of
lipogenic target genes such as Spot14 (Jump et al., 2001).
Increased energy expenditure and uncoupled oxidative
phosphorylation in LXR−/− mice
Real-time QPCR analysis in peripheral tissues revealed a strik-
ing, atypical increase in expression of genes involved in fat
utilization in skeletal muscle and white fat (Figure 5). In particu-
lar, we observed the strong, abnormal expression of uncou-
pling protein-1 (UCP-1) in LXR−/− mice under all dietary condi-
tions, although the levels were 2- to 3-fold higher in animals
on the high-fat diets (Figure 6A; Figure S2A). UCP-1 is the
mitochondrial protein that uncouples respiration and oxidative
phosphorylation in brown fat, but it is not normally expressed
in muscle or white fat. Comparing tissues, muscle UCP-1
mRNA achieved levels 25- to 55-fold higher than white adiposeCELL METABOLISM : APRIL 2005(Figure 6A). UCP-1 protein expression in LXR−/− skeletal mus-
cle was confirmed by immunoblot analysis of mitochondrial
protein fractions at 4% the level found in brown fat (Figure 6B).
In contrast, no UCP-1 protein was detected in wild-type ani-
mals on any of the diets (Figure 6B). Although ectopic expres-
sion of some brown adipose cells in the LXR−/− muscle mass
could not be completely ruled out, we note that no other adi-
pose-specific genes (e.g., adipocyte fatty acid binding protein,
aP2) were comparably elevated in these samples (Figure 6A).
In addition, histological examination of skeletal muscle from
mice on the Western diet revealed substantially fewer fat cells
between muscle fibers in LXR−/− versus wild-type mice (Figure
6C). Supporting this analysis, direct measurement of mitochon-
drial respiration from dissected muscle fibers revealed that res-
piration control ratios were significantly lower in LXR−/− mice,
demonstrating that uncoupled respiration was increased in
muscle (Figure 6D).
An intriguing aspect of UCP-1 induction in skeletal muscle
and white fat was that it occurred independent of increasing
the PPARγ coactivators PGC1α and β (Figure 5), which are be-
lieved to be required for UCP-1 expression in brown fat. In con-
junction with increased uncoupling, genes involved in fatty acid
and triglyceride synthesis (Fas, Acc, Scd-1, glycerol kinase
[Gyk]) and import (fatty acid transport protein-2, Fatp-2) were
upregulated in muscle from LXR−/− mice on the Western (Figure
5A) and high-fat-only diets (data not shown). This regulation
occurred despite decreased expression of SREBP-1c, consis-
tent with the suggestion that lipid metabolism is governed dif-
ferently by LXRs in muscle compared to liver (Muscat et al.,
2002). In contrast, SREBP-1c expression in adipose tissue in-
creased in LXR−/− mice, demonstrating that LXRs are not re-
quired for basal SREBP-1c expression in adipose tissues (Fig-
ure 5B). Surprisingly, no changes in oxidative gene expression
(including Ucp-1), histology, or morphology were observed in
brown fat, suggesting that this tissue does not contribute to
the resistance phenotype (Figure S1B and data not shown).
The results above suggested that the resistance to weight
gain observed in LXR−/− mice might have been due to in-
creased energy expenditure. To examine this possibility, wild-
type and LXR−/− mice were housed in metabolic cages and
assayed for oxygen consumption after feeding normal chow
versus high-fat diets. In comparison to wild-type littermates,
LXR−/− mice exhibited a 19% (nighttime) to 27% (daytime) in-
crease in oxygen consumption. This increase became more
significant (>30% over wild-type) during both the day (resting
period) and night (active period) when the animals were fed
both the Western and the high-fat-only diets (Figure 6E and
Figure S2B), demonstrating that LXR−/− mice are in a greatly
elevated oxidative state. The finding that fasting plasma ketone
bodies were not changed in LXR−/− mice (data not shown) was
further evidence that this energy consumption was occurring
within peripheral tissues.
Increased fatty acid synthesis in peripheral tissues
compensates for increased energy consumption in LXR−/−
mice fed high-fat-only but not Western diet
The finding that LXR−/− mice expend substantially more energy
in their peripheral tissues provides a convincing explanation for
why these animals are resistant to obesity on a Western diet
that includes both fat and cholesterol. However, these findings
do not explain why LXR−/− mice fed a high-fat-only diet (with-237
A R T I C L EFigure 5. Comparative expression analysis of genes involved in lipid and glucose metabolism in muscle and white adipose of wild-type and LXR−/− mice in response
to diet
A and B) QPCR using the comparative CT method was performed on RNA extracted from skeletal muscle (rectus femoris) (A), and white adipose tissue (WAT) (B) of wild-
type (wt) and LXR−/− mice fed for 7 weeks (C, chow; W, Western). The cycle time of the highest expressing group for each gene analyzed is indicated inside its
corresponding bar. * indicates statistical significance between animals of the same genotype fed different diets; # indicates significance between wild-type and
LXR−/− mice fed the same diet (p < 0.05, n = 5). Glut4, glucose transporter 4; Hsl, hormone sensitive lipase; Irs-1/2, insulin receptor substrate 1/2; Mcad, medium-
chain acyl-CoA dehydrogenase; Ptp-1b, protein-tyrosine phosphatase-1B. Abbreviations for other genes are defined in the text.out cholesterol) are still susceptible to obesity, since these
mice exhibited similar increases in UCP-1 and energy con-
sumption regardless of diet (compare Figure 6 to Figure S2).
Therefore, a compensatory mechanism must exist in LXR−/−
mice on the high-fat-only diet to permit them to gain weight in
spite of abnormally high energy loss. In Figures 7A and 7B,
we show that this compensation may be explained by a large,
unexpected increase in fatty acid synthesis in muscle (3-fold)
and white adipose tissue (4-fold) that occurred on the high-fat-
only diet but not on chow or Western diets. The absolute rates
of synthesis, particularly in white adipose, were enough to ac-238count for the weight gain on the high-fat-only diet. Interestingly,
fatty acid synthesis in liver remained substantially lower in
LXR−/− mice, regardless of diet (Figure 7C).
Discussion
LXRs as a model for obesity resistance
In this paper, the role of LXRs in regulating dietary fat metabo-
lism was investigated. Using complementary metabolic and
biochemical approaches, we show that LXR−/− mice are resis-
tant to diet-induced obesity by a mechanism that differs fromCELL METABOLISM : APRIL 2005
LXR regulation of dietary fat and cholesterolFigure 6. Increased metabolic rate and uncoupling of oxidative phosphorylation in LXR−/− mice
A) QPCR analysis (standard curve method) comparing expression of Ucp-1 and aP2 in rectus femoris muscle versus white adipose tissue (WAT) from wild-type (wt)
and LXR−/− mice after 7 weeks of feeding (C, chow; W, Western). The cycle time of the highest expressing group for each gene analyzed is indicated inside its
corresponding bar. *p < 0.05, **p < 0.01, n = 5.
B) Immunoblot analysis of mitochondrial UCP-1 from wild-type and LXR−/− mice treated as in (A). Lanes 1–4, protein extracts (100 g) from rectus femoris muscle;
lane 5, protein extract (2 g) from brown adipose tissue (BAT). Protein loading was confirmed by stripping and reprobing the blot with cytochrome C oxidase antibody
as a control.
C) Histology of rectus femoris muscle from wild-type and LXR−/− mice fed a Western diet for 7 weeks. The slides stained by hematoxyline and eosin show accumulation
of fat cells in between muscle fibers in wild-type but not LXR−/− mice and are representative of all fields in samples from several animals. Scale bar, 100 m.
D) Respiration control ratios measured from rectus femoris muscle mitochondrial extracts of wild-type and LXR−/− mice fed standard chow or Western diets for 3
weeks. Extracts were pooled from three animals, and the data are representative of duplicate experiments.
E) Oxygen consumption (VO2) was measured in wild-type (wt) and LXR−/− mice during daytime (resting) and nighttime (active) during week 4 of feeding a chow or
Western diet (n = 4). *p < 0.05 and **p < 0.01 indicate statistical significance between wild-type and LXR−/− mice fed the same diet. #p < 0.05 and ##p < 0.01 indicate
statistical significance between animals of the same genotype fed different diets.CELL METABOLISM : APRIL 2005 239
A R T I C L EFigure 7. Lipogenesis in peripheral tissues of wild-type and LXR−/− mice and a model for the dual regulatory role of LXRs in dietary cholesterol and fat metabolism
A–C) Fatty acid synthesis rates in skeletal muscle (A), white adipose (WAT) (B), and liver (C) were determined in wild-type and LXR−/− mice fed either chow, Western,
or high-fat-only diet for 17 days (n = 4). * indicates statistical difference between this value and that of mice of the same genotype fed different diets; # indicates
statistical significance between this value and that of all mouse groups of the other genotype (p < 0.05).
D) By sensing the cholesterol component of a lipid-rich diet, LXRs prevent accumulation of excess cholesterol and permit storage of dietary fat.
E) In the absence of LXRs, the balance between fat storage and oxidation is altered, and the accumulation of hepatic cholesterol now drives peripheral tissues to
aberrantly dissipate fat-derived energy.other animal models of obesity resistance (Chen and Farese,
2001; Yuan et al., 2001; Ntambi et al., 2002; Kamei et al., 2003;
Wang et al., 2003; Um et al., 2004). One factor that contributes
to this phenotype is the defect LXR−/− mice have in hepatic
lipogenesis. Even on a standard chow diet, LXR−/− mice
weighed less (Figure 1), had lower hepatic and plasma lipid
levels, and were unable to properly synthesize fatty acids and
triglycerides or store them in liver and adipose tissue (Figure
2). These defects are due in large part to LXR’s role as a regula-
tor of the hepatic SREBP-1c transcriptional cascade that is
normally activated upon feeding but is almost entirely absent
in LXR−/− animals (Figure 3A). However, just the loss of SREBP-
mediated lipogenesis in LXR−/− mice is not enough to explain
fully the inability of these animals to gain weight on a Western
high-fat, high-cholesterol diet. This conclusion is based on our
observation that SREBP-1c null mice do not recapitulate the
obesity resistance phenotype, regardless of diet (Figure 4), and
suggests that a separate defect underlies the fate of the dietary
fat in LXR−/− mice.
In addition to their lean body mass, the LXR−/− mice dis-
played an abnormally high metabolic rate compared to their240wild-type littermates (Figure 6E). This lean and hypermetabolic
basal phenotype of LXR−/− mice is reminiscent of the pheno-
type described in mice lacking SCD-1 (Cohen et al., 2002;
Ntambi et al., 2002; Dobrzyn et al., 2004). Scd-1 is a down-
stream target of the LXR/SREBP-1c transcriptional cascade
(Repa et al., 2000a). Indeed, hepatic SCD-1 mRNA levels were
decreased substantially in LXR−/− mice regardless of diet (Fig-
ure 3A), suggesting that at least part of the basal LXR−/− phe-
notype might be due to decreased SCD-1. Although there are
also clear differences between the LXR and SCD-1 knockout
models (e.g., liver fatty acid oxidation was elevated in SCD-1−/−
but not LXR−/− mice), it will be of interest to test whether mice
lacking SCD-1 exhibit a similar increase in uncoupled oxidative
phosphorylation in muscle and adipose as that found in LXR−/−
mice.
Where does the fat go?
Another unusual feature of the LXR null mice was that they
maintained substantially lower circulating plasma triglycerides
and displayed almost undetectable levels of plasma VLDL tri-
glycerides even when fed the high-fat/high-cholesterol West-CELL METABOLISM : APRIL 2005
LXR regulation of dietary fat and cholesterolern diet. Since both Lpl and Fatp-1 were upregulated in liver of
LXR−/− mice in a cholesterol-dependent manner, another pro-
cess that may contribute to lower plasma triglycerides is their
incorporation into cholesterol esters in liver. Because the nor-
mal endogenous lipogenic pathway is impaired in LXR−/− mice,
an increase in hepatic triglyceride uptake would be required to
esterify the large amounts of cholesterol that accumulated due
to defective elimination of hepatic cholesterol. However, esteri-
fication would not be expected to completely prevent periph-
eral fat storage and obesity in LXR−/− mice, since this process
can only account for a fraction of the total dietary fat and in
any case would favor an increase rather than a steady state or
decrease in total body weight.
A more plausible explanation for the low levels of circulating
triglycerides and obesity resistance in LXR−/− mice is that the
dietary fat is taken up and burned in peripheral tissues. This
conclusion is strongly supported by the unprecedented upreg-
ulation of UCP-1 expression and uncoupled oxidative phos-
phorylation in muscle and adipose, and the marked increase in
metabolic rate observed in LXR−/− mice (Figure 6). Although the
reason for the unexpected UCP-1 expression in LXR−/− mice
requires further investigation, its relevance to the observed
phenotype has been confirmed by earlier studies showing that
similar levels of ectopic UCP-1 expression in either muscle or
adipose tissue of transgenic mice also caused increased en-
ergy expenditure and prevented obesity (Kopecky et al., 1995;
Kopecky et al., 1996; Li et al., 2000). Another unprecedented
finding in the LXR−/− animals was that their increased energy
expenditure was not associated with changes in brown adi-
pose (Figure S1B) or the expression of PGC1α or PGC1β (Fig-
ure 5), the coregulatory transcription factors that normally func-
tion as metabolic switches that lead to fat oxidation (Lin et al.,
2003; Puigserver and Spiegelman, 2003).
What is the cholesterol-derived signal?
Perhaps the most distinguishing and striking feature of the
LXR−/− phenotype is the requirement for dietary cholesterol to
promote obesity resistance upon high fat intake (Figure 1). In-
deed, when the LXR null mice were fed a high-fat diet that did
not contain cholesterol, these animals gained weight similar to
their wild-type littermates. Since defective hepatic lipogenesis
and increased energy expenditure were observed in all LXR−/−
animals (regardless of diet), some compensatory pathway must
have existed to overcome the high level of fat oxidation in
these animals when they were fed a high-fat diet without cho-
lesterol. Our results indicate that at least two diet-specific phe-
notypes likely accounted for the cholesterol-dependent resis-
tance to obesity in LXR−/− mice. First, we found a substantial
compensatory increase in fatty acid synthesis in muscle and
white adipose of LXR−/− mice fed a high-fat-only but not West-
ern diet (Figures 7A and 7B). The high level of fat production
in these tissues was enough to explain the weight gain in these
animals. This unusual compensatory mechanism for the main-
tenance of body lipids is reminiscent of a similar finding re-
ported for the liver-specific SREBP cleavage-activating protein
(SCAP) knockout mice (Kuriyama et al., 2005). These mice
were suggested to compensate for their decreased hepatic
fatty acid synthesis by exhibiting a balanced increase in syn-
thesis in peripheral tissues, primarily adipose.
The second diet-specific phenotype we observed was the
increased production of active thyroid hormone from its in-CELL METABOLISM : APRIL 2005active precursor in liver due to ectopic expression and activity
of DIO2. This abnormal expression of DIO2 occurred only in
LXR−/− mice fed the Western diet and was not present when
animals were fed only high fat (Figure 3) or only high cholesterol
(data not shown). Given the well-characterized role of DIO2 in-
duction in controlling adaptive energy expenditure (Bianco and
Silva, 1987), ectopic expression of DIO2 in LXR−/− mice would
be expected to have noticeable effects in liver. Consistent with
this idea, target genes involved in fatty acid transport and me-
tabolism were increased significantly (Fatp-1, B2AR, Ucp-2,
Lpl) in liver from LXR−/− mice on a Western diet (Figure 3B).
At present, it remains unclear how cholesterol regulates Dio2
expression in LXR−/− mice or how this regulation might sup-
press the compensatory fatty acid synthesis rates seen in the
periphery of LXR−/− animals that lack the cholesterol compo-
nent of a high-fat diet. The mechanism of this aberrant regula-
tion and the possible involvement of other sterol-regulated
transcription factors such as SREBP-1a and SREBP-2 are un-
der investigation. Although the metabolic changes taking place
in the periphery and those observed in the liver of LXR−/− mice
on Western diet might constitute two independent, unrelated
events, it is possible that these processes, like many others in
animal physiology, are interconnected and integrate together
to affect systemic homeostasis. Because liver is the major site
for processing dietary lipids and undergoes dramatic choles-
terol-induced metabolic changes in LXR−/− animals (e.g., cho-
lesterol accumulation, altered bile acid metabolism, and gene
expression changes), it is reasonable to conclude that the liver
may be the source of the cholesterol-derived signal.
LXRs integrate cholesterol and triglyceride homeostasis
The data presented here support a model in which LXRs’ regu-
lation of fat metabolism is integrated through their key role in
maintaining cholesterol homeostasis (Figure 7D). Previous
work has shown that LXRs act as sterol sensors and limit cho-
lesterol accumulation by decreasing its absorption and increasing
its reverse transport and catabolism (reviewed in Repa and
Mangelsdorf [2002]). At the same time, activation of the LXR
pathway by dietary cholesterol would be expected to stimulate
hepatic triglyceride synthesis and fat storage by upregulating
the SREBP-1c metabolic cascade and mimicking the effects of
insulin. In agreement with this latter conclusion, we and others
have shown that LXRs are required for both the basal expres-
sion (Figure 3A; Repa et al. [2000a]) and the insulin-induced
expression (Chen et al., 2004) of SREBP-1c and its down-
stream target genes. LXRs have also been implicated in he-
patic carbohydrate metabolism by stimulating genes involved
in glucose storage and inhibiting gluconeogenesis (Figure S1A,
Cao et al. [2003], Dalen et al. [2003], Laffitte et al. [2003]), which
would be consistent with their role in promoting energy stor-
age. In the LXR−/− animals, these pathways are missing, and
the increased accumulation of sterols along with the aberrant
increase in oxidative gene expression now shift the energy bal-
ance toward dissipation rather than storage (Figure 7E). Thus,
from an evolutionary point of view, the LXRs have solved the
important metabolic conundrum of how to limit the accumula-
tion of cholesterol, which animals can synthesize themselves,241




Wild-type, LXRα/β knockout mice (LXR−/−) (Peet et al., 1998; Repa et al.,
2000b) and SREBP-1c knockout mice (SREBP-1c−/− provided by Drs.
Brown and Goldstein) (Liang et al., 2002) were maintained in a mixed strain
background (C57BL/6:129 SvEv) and housed in a temperature-controlled
environment with 12 hr light/dark cycles. Age-matched (4–5 months old)
male mice had free access to water and were fed ad libitum (for 3 or 7
weeks) from one of three diets: standard rodent chow (TD 7001, Harlan
Teklad, Madison, WI) that contains 4% (w/w) total lipid (<12% of its calories
as animal fat) and %0.04% (w/w) cholesterol; a Western-style diet (TD
88137, Harlan Teklad, Madison, WI) containing 21% (w/w) total lipid (42%
calories as anhydrous milk fat [65% saturated, 32% monounsaturated, 3%
polyunsaturated fats]) and 0.2% (w/w) total cholesterol (of which 0.05% is
contributed by milk fat and 0.15% is added); or a high-fat-only diet, which
has the same constituents as the Western diet but lacks additional choles-
terol. Body weight was recorded weekly, and food intake was measured
biweekly. Total body fat mass was analyzed weekly by NMR using the Mini-
spec mq spectrometer (Bruker). At the end of the feeding period, mice were
anesthetized with halothane and exsanguinated via the ascending vena
cava prior to organ harvest. Blood was kept on ice in heparin-coated tubes
(Microvette 500 LH; Sarstedt, Inc.) and centrifuged (1500 × g for 15 min at
4°C), and the plasma was stored at −20°C until analysis. For lipoprotein and
TSH measurements, blood was collected in EDTA-coated tubes. Plasma
for lipoprotein measurements was kept at 4°C in the presence of protease
inhibitors prior to analysis. Tissues were harvested for analyses as de-
scribed below. All experiments were approved by the Institutional Animal
Care and Research Advisory Committee at the University of Texas South-
western Medical Center.
Lipid absorption
On week 5 of the dietary study, stools were collected from individually
housed mice over 72 hr. Lipid content of diets and stools was determined
gravimetrically and used to calculate the fraction of consumed lipid that
was absorbed as described in Figure 1D (Schwarz et al., 1998).
Liver triglycerides and cholesterol
Cholesterol was extracted from saponified liver (0.3 g) with petroleum ether
and quantitated by gas chromatography using stigmasterol as an internal
standard. Other lipids were extracted from liver (0.2 g) in chloroform:metha-
nol (2:1, v/v). Extracts were then washed once in 50 mM NaCl and twice in
0.36 M CaCl2/methanol. The organic phase was separated and brought up
to 5 ml with chloroform. Ten microliters of chloroform:Triton X-114 (1:1, v/v)
was added to duplicate 100 l aliquots of each extract and standards
(Sigma Diagnostics), which were then air dried overnight. Colorimetric enzy-
matic assays were performed using 1 ml triglyceride reagent (ThermoTrace).
After 20 min, optical densities of each sample were read at 520 nm and
compared to prepared standards.
In vivo measurements of hepatic fatty acid synthesis
Rates of fatty acid synthesis were measured in liver, skeletal muscle
(hindlimb), and epididymal white adipose tissue of wild-type and LXR−/−
mice during the early light cycle as described (Horton et al., 1998).
Plasma analyses and glucose tolerance
For glucose tolerance, mice were fasted overnight before receiving an in-
traperitoneal injection of 20% D-glucose (Sigma) (1 g/kg body weight). At
0, 15, 30, 45, 60, and 120 min after injection, 5–10 l of blood was drawn
from the tail and blood glucose levels assayed using an Elite XL Glucometer
(Bayer). For other plasma chemistry analyses, two measurements were per-
formed: one with and one without a 4 hr fast. Different enzymatic assays
were used for each analyte, including total cholesterol (Roche Diagnostics),
plasma triglycerides (ThermoTrace), free fatty acids (Roche), insulin (Crys-
talChem), leptin (CrystalChem), ketone bodies (Ranbut, Randox), and total
T3/T4 (DPC Coat-A-Count). Plasma lipoprotein levels were analyzed by fast
protein liquid chromatography using two serial Superose HR6 columns, fol-242lowed by enzymatic analysis of their cholesterol and triglyceride contents
using the kits described above. TSH levels were determined by RIA using
an anti-mouse TSH antibody at the National Hormone and Pituitary Pro-
gram (Dr. A.F. Parlow, Harbor-UCLA Medical Center).
Calorimetry measurements
Utilizing a modified Oxymax system (Columbus Instruments, Columbus,
OH), a series of ten airtight calorimetric chambers were engineered to as-
sess the metabolic activity of mice over one 12 hr light/12 hr dark cycle.
Two empty chambers served as reference controls. Standard gas mixtures
of O2, CO2, and N2 were used to calibrate the system prior to the initiation
of each experiment. Room air gas was infused into each chamber at a rate of
415 cc/min. Every 30 min, O2 and CO2 concentrations were measured in
each chamber, and oxygen consumption (VO2) and carbon dioxide pro-
duction (VCO2) were calculated and averaged for the light and dark cycle
for each mouse. Mice were analyzed in two sets over consecutive days
(eight mice per set, four per genotype from two diets) in individual calorime-
ter chambers containing water, food (chow versus high-fat diets) maintained
at constant temperature and humidity. Baseline data were collected prior to
the initiation of the special food diet and then every 2 weeks (for a total of
6 weeks) after randomization to one of the two food diets.
Real-time PCR analysis
Total RNA was extracted from tissues using RNA STAT-60 (Tel-Test, Inc.),
treated with DNase I (RNase-free, Roche Molecular Biochemicals), and re-
verse transcribed into cDNA with random hexamers using the SuperScript
II First-Strand Synthesis System (Invitrogen). Primers for each mRNA were
designed using Primer Express Software (PerkinElmer Life Sciences) based
on sequence data from GenBankTM (Table S1) and were validated as de-
scribed (Bookout and Mangelsdorf, 2003). Real-time PCR reactions con-
tained 10–25 ng cDNA, 150 nM of each primer, and 5 l 2X-Jump Start
SYBR Green PCR Master Mix (Sigma) in 10 l total volume. PCR reactions
were performed in triplicate using an Applied Biosystems Prism 7900HT
instrument. Relative mRNA levels were calculated using either the compara-
tive CT or standard curve methods normalized to cyclophilin mRNA or 18S
RNA, respectively.
Deiodinase activity assay
Deiodinase activities were assayed as described (Curcio-Morelli et al., 2003)
in the presence of 20 mM DTT for DIO1 and DIO2 and 10 mM DTT for D3.
Briefly, tissue fragments were sonicated in 0.1 M K2PO4, 1 mM EDTA (pH
6.9) containing DTT and 0.25 M sucrose. Each sample (200 g protein) was
assayed in duplicate using 0.5 nM or 100 nM 125I-T4 (NEN Life Science
Products, Inc., Boston, MA). Catalytic activities of both DIO1 and DIO2 are
detected in the presence of 0.5 nM 125I-T4, but only DIO1 activity is de-
tected in the presence of 100 nM 125I-T4. DIO2 activity was calculated
based on the difference of 125I produced between the two conditions. A
similar approach was used to measure DIO3 activity, except that 0.1 nM
125I-T3 (NEN Life Science Products, Inc., Boston, MA) was used as sub-
strate. All results were corrected for random deiodination.
Western blotting
Mitochondrial protein fractions were prepared as described (Bhattacharya
et al., 1991) from skeletal muscle and interscapular brown adipose tissue,
resolved on a 12% SDS-polyacrylamide gel, and electrotransferred to a
PVDF membrane (Amersham). The membrane was then hybridized with
rabbit anti-mouse UCP-1 antiserum (recognizing the C terminus of mouse
and rat UCP-1) (Alpha Diagnostic International, San Antonio) at a 1:3000
dilution, followed by secondary antibody incubation at a 1:5000 dilution.
UCP-1-specific bands were detected by chemiluminescence (ECL kit, Am-
ersham).
Histological procedures
Rectus femoris muscle was fixed in formalin (Accustain, Sigma), embedded
in paraffin wax, sectioned, and stained with hematoxylin and eosin. Sec-
tions were examined under bright-field microscopy at 100× magnification.
Muscle mitochondrial respiration
Purified mitochondrial fractions were prepared as described (Bhattacharya
et al., 1991) and resuspended in the presence of 0.5% BSA. Fractions con-CELL METABOLISM : APRIL 2005
LXR regulation of dietary fat and cholesteroltaining 1 mg protein were injected into a magnetically stirred sample cham-
ber of a model 110 fiberoptic oxygen monitor (Instech Laboratories, Plym-
outh Meeting, PA). Oxygen consumption was then recorded continuously
for 15 min, during which the following were sequentially injected into the
chamber: 3 mM each of malate and glutamate (Sigma), followed by 270 M
ADP and 540 M ADP (Sigma). As a control, 2 M of the reducing agent
carbonyl cyanide chlorophenylhydrazone (Sigma) was injected followed by
540 M ADP. Respiration control ratios were quantitated according to Esta-
brook (1967).
Statistical analyses
Values are expressed as mean ± standard error of the mean. Significant
differences between mean values were evaluated using two-tailed, unpaired
Student’s t test (when two groups were analyzed) or one-way ANOVA fol-
lowed by Student Newman-Keuls test (for three or more groups).
Supplemental Data
Supplemental Data include two figures and one table and can be found
with this article online at http://www.cellmetabolism.org/cgi/content/full/1/
4/231/DC1/.
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